The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.

Authors
Publication date
28 August 2017
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ezid

    redirect
    oaiark:/13030/qt7xs7c1z4
    Last time updated on 02/05/2020